Waccamaw Oncology Georgetown, SC - 29440

Waccamaw Oncology is categorized under Oncologists in Georgetown, SC and active since 2002.

Waccamaw Oncology was established in 2002, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Oncologists business, which does work in the B2C market, and is classified as a Oncologists, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Donna Mullins, Office Manager at the company’s single location by writing to 2405 North Fraser St # 1, Georgetown, South Carolina SC 29440 or by phoning (843) 545-7274. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Waccamaw Oncology
Contact Person: Donna Mullins, Office Manager
Address: 2405 North Fraser St # 1, Georgetown, South Carolina 29440
Phone Number: (843) 545-7274
Website Address: waccamawoncology.com
Annual Revenue (USD): $2.500.000 to $4.999.999
Founded: 2002
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Oncologists
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Waccamaw Oncology was started in 2002 to provide professional Oncologists under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.

Feel free to contact Donna Mullins, Office Manager for inquiries that concern Waccamaw Oncology by calling the company number (843) 545-7274, as your correspondence is most welcome. Additionally, the physical location of the single location of Waccamaw Oncology can be found at the coordinates 33.40887,-79.28663 as well as the street address 2405 North Fraser St # 1 in Georgetown, South Carolina 29440.

For its online presence, you may visit Waccamaw Oncology’s website at waccamawoncology.com and engage with its social media outlets through on Twitter and on Facebook.